NCT00965081

A Study for Adult Patients With Fibromyalgia

A Randomized, Double-Blind Comparison of Duloxetine 30 mg QD and Placebo in Adult Patients With Fibromyalgia

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 308 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The main purpose of this study is to determine if 30 milligrams (mg) of duloxetine is effective in the treatment of fibromyalgia compared to placebo.

Conditions

• Fibromyalgia, Primary
• Fibromyalgia, Secondary

Interventions

Type	Name	Description
DRUG	Duloxetine	30 milligrams (mg) dose daily (QD) by mouth (po) at the same time each day for 12 weeks
DRUG	Placebo	QD po at the same time each day for 12 weeks

Timeline

• Start date: 2009-09-01
• Primary completion: 2010-11-01
• Completion: 2010-11-01
• First posted: 2009-08-25
• Last updated: 2011-11-03
• Results posted: 2011-11-03

Locations

4 sites across 1 country: Mexico